Medical Statistics Consulting for Publishable Research

A promising clinical question can lose its value long before manuscript submission. An underpowered sample, an imprecise outcome definition, missing-data decisions made after results are visible, or a mismatched statistical test can all weaken a study that required substantial time and patient access. Medical statistics consulting is most valuable when it protects the scientific logic of a project from its first protocol decision through the final response to peer review.

For physicians, residents, health professionals, and academic researchers, statistical support should not mean receiving a table of p-values at the end of a study. It should mean gaining a defensible analytical pathway: one that fits the research question, respects ethical commitments to participants, and meets the methodological expectations of the intended journal.

What medical statistics consulting should solve

Clinical research has a practical purpose. A study may seek to compare treatment outcomes, identify prognostic factors, assess diagnostic performance, validate a scale, or estimate the prevalence of a condition. Each purpose requires different decisions about design, sample selection, variables, and analysis.

A meaningful consultation begins by clarifying the primary question. Is the goal to establish a difference, estimate an effect, predict an outcome, or evaluate agreement between measurements? These objectives sound similar in everyday language, but they lead to different statistical models and different reporting standards.

For example, a retrospective comparison of two surgical techniques may require adjustment for baseline imbalance, not only a simple comparison of group averages. A diagnostic study needs attention to sensitivity, specificity, confidence intervals, and the reference standard. A longitudinal study must account for repeated measurements within the same patient. Choosing an analysis because it is familiar, rather than because it fits the data-generating process, is a common source of reviewer criticism.

Medical statistics consulting should therefore address the full chain of decisions: research design, sample size, variable structure, data quality, model selection, result interpretation, tables and figures, and methods reporting. The output is not merely a statistical file. It is an analysis that the research team can understand, defend, and describe accurately.

Begin before data collection when possible

The most efficient time to seek support is before the first participant is enrolled or the first retrospective record is extracted. At this stage, changes are still inexpensive. Once data collection is complete, a poorly defined primary outcome or inadequate sample size may be impossible to correct.

Turn the clinical idea into a measurable protocol

A protocol should state who will be included, which variables will be collected, how the main outcome will be measured, and which comparison or association is of primary interest. It should also distinguish primary outcomes from secondary or exploratory outcomes.

This distinction matters because testing many outcomes without a clear hierarchy increases the chance of chance findings. Exploratory analyses can be useful and publishable when they are identified honestly. Problems arise when post hoc results are presented as if they had been the original hypothesis.

Consultation at the protocol stage can also improve case report forms and database structure. Consistent coding for diagnoses, medications, laboratory units, follow-up times, and reasons for exclusion saves substantial time later. It also reduces preventable ambiguity in multicenter or team-based studies.

Plan sample size around the primary aim

Sample size planning is often reduced to a formula, but the formula is only the final step. The inputs must reflect a clinically meaningful effect, anticipated variability or event rate, acceptable uncertainty, and the likely availability of participants.

A small study is not automatically unacceptable. Rare diseases, pilot studies, and early feasibility work may necessarily involve limited samples. In those settings, transparent estimation with confidence intervals may be more informative than overstating statistical significance. Conversely, a very large database can produce statistically significant but clinically trivial findings. Medical relevance and statistical evidence should be evaluated together.

Choose methods that match the data, not habits

The question “Which test should I use?” is useful, but it should come after several other questions. What is the outcome type? Are observations independent? Is there clustering by hospital, physician, or patient? Is follow-up time relevant? Are there confounders? How much missing data exists, and why is it missing?

For a binary outcome such as mortality or complication status, logistic regression may be appropriate when the aim is to estimate adjusted associations. For time-to-event outcomes, survival analysis may be needed. For continuous measurements collected repeatedly over follow-up, mixed-effects models can be preferable to running separate tests at each visit.

There is no single “best” method independent of the study context. More complex models are not always better. A simple analysis may be the clearest and most reliable choice when the design and data support it. Complexity is justified when it addresses a real feature of the study, such as repeated measures, confounding, nonlinearity, or clustering.

Handle missing data and outliers transparently

Deleting incomplete records without examination can change the study population and bias estimates. Yet advanced imputation is not automatically appropriate either. The right approach depends on the amount of missingness, the variables affected, and the plausible reason values are absent.

Outliers require the same discipline. A value may be an entry error, a measurement problem, or a genuine clinical observation. It should not be removed simply because it makes a result less favorable. A documented data-cleaning process and, where appropriate, sensitivity analyses help demonstrate that conclusions do not depend on arbitrary decisions.

Reporting is part of the analysis

Many manuscripts fail methodological review not because the analysis was necessarily wrong, but because the methods are too vague to evaluate. Statements such as “appropriate statistical tests were used” do not allow editors, reviewers, or readers to assess the work.

A publication-ready statistical section should identify the primary outcome, describe summary measures, name the models or tests used, define adjustment variables, state the significance threshold where relevant, report confidence intervals, and explain treatment of missing data. It should also make clear whether analyses were prespecified, secondary, or exploratory.

Results need the same care. A p-value alone does not convey the magnitude or precision of an effect. Depending on the question, researchers should report mean differences, odds ratios, hazard ratios, risk differences, correlation coefficients, diagnostic accuracy measures, or other relevant effect estimates with confidence intervals.

Tables should answer a specific question rather than repeat every output generated by software. Figures should clarify patterns, distributions, or effect estimates without exaggerating certainty. Journal requirements differ, but clarity, traceability, and consistency are expected across SCI, SSCI, ESCI, TR Dizin, and field-indexed publications.

Ethical consulting protects authorship and credibility

Ethical practice is central to credible medical research. Statistical consultation should support researchers in making valid decisions, not manufacture favorable findings or conceal inconvenient results. Selective reporting, unjustified subgroup analyses, undisclosed outcome changes, and inappropriate exclusion of observations can damage both a manuscript and an academic record.

The consultant’s role should be defined transparently. Researchers remain responsible for the clinical rationale, data provenance, and final interpretation. Where an analyst makes a substantial intellectual contribution to design, analysis, interpretation, or manuscript development, authorship should follow the journal’s criteria. Where the contribution is limited to technical assistance, acknowledgment may be more appropriate.

This clarity is particularly important for specialty theses and promotion-oriented publications. A defensible thesis is not one that merely reaches significance. It is one whose methods, results, and limitations can be explained confidently before a thesis committee, editor, or reviewer.

How to prepare for a consulting engagement

A productive first meeting does not require a perfect dataset. It does require a clear starting package: the research question, draft protocol or thesis plan, inclusion and exclusion criteria, a data dictionary if available, sample size information, and the target journal or publication goal. If data have already been collected, provide the original export and explain how variables were obtained.

Researchers should also state practical constraints early. A deadline for a residency thesis, restricted access to patient records, a limited expected sample, or a journal’s specific reporting format can affect the analysis plan. These constraints do not prevent good research, but they should shape realistic decisions from the beginning.

Dekartezyen İstatistik approaches this work as an applied academic partnership, combining discipline-specific statistical expertise with attention to scientific ethics, thesis requirements, and publication standards. The objective is not to replace the researcher’s authorship of the study, but to make the study methodologically stronger and publication-ready.

The best time to ask whether an analysis is defensible is before a reviewer asks it. A well-planned consultation gives clinical research a clearer path from a relevant question to evidence that can withstand scrutiny.